SCHEMBL6745974

SCHEMBL6745974

Cc1[c]nc2c(O)cccc2c1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.40
CYP1A2 P05177 3/20 0.40
PARP1 P09874 2/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
METAP2 P50579 2/20 0.39
TRPA1 O75762 2/20 0.38
ATM Q13315 1/20 0.38
SLC6A2 P23975 1/20 0.37
HTT P42858 1/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
ACHE P22303 1/20 0.36
MAPT P10636 3/20 0.36
TSHR P16473 3/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
ALOX12 P18054 1/20 0.36
L3MBTL1 Q9Y468 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4799968 0.74 OPRK1 (0.38) KDM4ESLC6A2HTTKMT2AMAPT
SCHEMBL18106120 0.69 PARP1 (0.50) KDM4ECYP1A2PARP1CYP2D6CYP2C9
SCHEMBL1986163 0.68 GPR3 (0.39) KDM4ECYP1A2PARP1SLC6A2HTT
SCHEMBL1715320 0.68 CCR1 (0.61) KDM4ECYP1A2PARP1CYP2D6CYP2C9
SCHEMBL659910 0.67 ACHE (0.40) KDM4ECYP1A2PARP1CYP2D6CYP2C9
SCHEMBL4303286 0.67 CCR1 (0.59) KDM4ECYP1A2PARP1CYP2D6CYP2C9
SCHEMBL4310097 0.67 CCR1 (0.59) KDM4ECYP1A2PARP1CYP2D6CYP2C9
SCHEMBL13313366 0.67 CYP1A2 (0.64) KDM4ECYP1A2PARP1CYP2D6CYP2C9
SCHEMBL4296866 0.67 CCR1 (0.59) KDM4ECYP1A2PARP1CYP2D6CYP2C9
SCHEMBL30284810 0.67 CCR1 (0.59) KDM4ECYP1A2PARP1CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040263952-A1 Bridged polysesquioxane host matrices containing lanthanides chelated by organic guest ligands, and methods of making such matrices LUCENT TECHNOLOGIES, INC. (US) 2004-12-30 US disclosed